Gsk (GSK) EBITDA (2009 - 2026)
Gsk (GSK) posted quarterly EBITDA of $645.3 million for Q2 2026, down 76.09% year-over-year from $2.7 billion in Q2 2025, and down 79.12% quarter-over-quarter from $3.1 billion in Q1 2026.
Gsk (GSK) EBITDA (2009 - 2026) Analysis & Trends
Gsk's EBITDA history runs 18 years deep, the most recent figure standing at $645.3 million for Q2 2026.
- In Q2 2026, EBITDA fell 76.09% year-over-year to $645.3 million; the TTM figure through Jun 2026 stood at $12.9 billion (up 31.9% YoY), while the FY2025 annual figure was $10.5 billion, up 103.47% from the prior year.
- EBITDA for Q2 2026 stood at $645.3 million, down from $3.1 billion in the prior quarter.
- The five-year high for EBITDA was $5.6 billion in Q4 2025, with the low at $245.6 million in Q3 2024.
- The 5-year median for EBITDA is $2.7 billion (2023), against an average of $2.7 billion.
- The sharpest annual moves came in 2024 and 2025: EBITDA plunged 90.05% in 2024, then jumped 1324.82% in 2025.
- Gsk's EBITDA stood at $4.0 billion in 2022, then jumped by 32.44% to $5.2 billion in 2023, then decreased by 23.21% to $4.0 billion in 2024, then surged by 40.09% to $5.6 billion in 2025, then plunged by 88.55% to $645.3 million in 2026.
- Business Quant data shows GSK's EBITDA at $645.3 million in Q2 2026, $3.1 billion in Q1 2026, and $5.6 billion in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.88 Bn | 625.12 Bn | 17.26 Bn | 7.14 Bn |
| 2 | AbbVie | 463.46 Bn | 456.89 Bn | 12.70 Bn | 6.43 Bn |
| 3 | Merck | 367.92 Bn | 360.78 Bn | 12.21 Bn | -584.00 Mn |
| 4 | Novartis Ag | 297.71 Bn | 290.02 Bn | 11.24 Bn | 4.75 Bn |
| 5 | Astrazeneca | 255.55 Bn | 250.65 Bn | 12.86 Bn | 3.16 Bn |
| 6 | Amgen | 234.52 Bn | 220.53 Bn | 7.24 Bn | 3.51 Bn |
| 7 | Gilead Sciences | 178.22 Bn | 175.04 Bn | 6.22 Bn | -10.39 Bn |
| 8 | Pfizer | 158.57 Bn | 146.88 Bn | 10.94 Bn | 4.27 Bn |
| 9 | Gsk | 105.32 Bn | 101.15 Bn | 8.24 Bn | 645.35 Mn |
| 10 | Sanofi | 54.20 Bn | 46.82 Bn | 10.79 Bn | 16.77 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 645.35 Mn |
| Mar 31, 2026 | 3.09 Bn |
| Dec 31, 2025 | 5.64 Bn |
| Sep 30, 2025 | 3.50 Bn |
| Jun 30, 2025 | 2.70 Bn |
| Mar 31, 2025 | 2.79 Bn |
| Dec 31, 2024 | 4.03 Bn |
| Sep 30, 2024 | 245.57 Mn |
| Jun 30, 2024 | 2.08 Bn |
| Mar 31, 2024 | 1.89 Bn |
| Dec 31, 2023 | 5.24 Bn |
| Sep 30, 2023 | 2.47 Bn |
| Jun 30, 2023 | 2.68 Bn |
| Mar 31, 2023 | 2.53 Bn |
| Dec 31, 2022 | 3.96 Bn |
| Sep 30, 2022 | 1.40 Bn |
| Jun 30, 2022 | 1.36 Bn |
| Mar 31, 2022 | 3.08 Bn |
| Dec 31, 2021 | 3.35 Bn |
| Sep 30, 2021 | 1.90 Bn |